Table 4.
Association of urine biomarkers with active LN status after adjusting for confounding factors.
| Active LN vs inactive SLE | ||||||
|---|---|---|---|---|---|---|
| Protein | Race as co-factor | Race + age co-factors | Race + prednisone co-factors | |||
| p-value | q-value | p-value | q-value | p-value | q-value | |
| ALCAM | * | * | * | * | * | ns |
| BFL-1 | *** | ** | *** | ** | ** | ** |
| Calpastatin | *** | *** | *** | *** | *** | ** |
| FcgRIIBC | ns | ns | ns | ns | ns | ns |
| Hemopexin | ** | ** | ** | ** | ** | ** |
| MCP-1 | ** | * | ** | * | ** | * |
| Peroxiredoxin-6 | ns | ns | ns | ns | ns | ns |
| PF-4 | *** | *** | *** | *** | *** | *** |
| Properdin | *** | *** | *** | *** | *** | *** |
| sE-Selectin | ** | ** | ** | ** | ** | ** |
| TFPI | ns | ns | ns | ns | ns | ns |
| VCAM-1 | ** | ** | ** | ** | ** | ** |
***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. The same nomenclature is used for significance after multiple testing correction (q-values).